Pharmexcil’s iPHEX 2026 records USD 4.5-5 billion in potential business discussions, attracting buyers from 128 countries, with the next edition set for 2027.
IPHEX 2026 | 11/09/2026 | By News Bureau | 245
The Central Drugs Standard Control Organisation (CDSCO) signals smarter, risk-based pharma regulation at iPHEX 2026, calling for proportionate enforcement, simpler compliance and clearer regulatory norms.
IPHEX 2026 | 09/09/2026 | By News Bureau | 103
Union Minister of Commerce and Industry Piyush Goyal inaugurated Bharat Health Global Expo 2026, urging India to leverage its generics strength to lead in complex, high-value medicines.
IPHEX 2026 | 08/09/2026 | By News Bureau
Pharmexcil Eyes USD 1.4 Billion Pharma Exports as iPHEX 2026 Opens New Global Markets
600+ overseas business delegates to engage with Indian pharma companies as Pharmexcil looks to translate global buyer participation into new markets and commercial opportunities.
IPHEX 2026 | 04/09/2026 | By News Bureau | 132
PHARMEXCIL Engages Government Leaders to Strengthen Indian Pharmaceutical Export Growth
The Pharmaceuticals Export Promotion Council of India (PHARMEXCIL) held a series of high-level discussions with key government stakeholders to align policy priorities, accelerate export momentum and reinforce India’s position in global pharmaceutical markets.
IPHEX 2026 | 06/01/2026 | By News Bureau | 454
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy